# Ascendis Pharma LLC – FDA Inspection, Mar 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/ascendis-pharma-llc/6d5dd80a-ac1f-44a2-9413-1a4318eb357b
Source feed: FDA_Inspections

> FDA inspection 1306552 of Ascendis Pharma LLC, March 06, 2026. 2 citations under 21 CFR parts 314 and 600. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306552
- Company Name: Ascendis Pharma LLC
- Inspection Date: 2026-03-06
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)
- [Issuing Officer](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.keypedia.com/companies/ascendis-pharma-llc/e8b83440-3eb0-4052-8586-04a5ff45ff68

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
